Register for our free email digests:
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
A review of recent US FDA citations has industry concerned about the extent to which agency investigators may be reviewing security video archives as part of their pharmaceutical manufacturing plant inspections.
Latest From Manufacturing
An industry group has proposed some best practices for validating pharmaceutical packaging processes to minimize packaging defects. The paper is designed to fill a knowledge gap: while there is no shortage of information on how manufacturers can validate their manufacturing processes, less information is available on how manufacturers can validate packaging.
Guidance, which is undergoing clearance, will address other products as well and might be released by the end of the year.
A House committee has requested a briefing from Merck on the June 27 NotPetya malware attack that has impeded manufacturing operations, and on the pharmaceutical company's subsequent remediation efforts. Meanwhile, a pharmaceutical industry group is bringing experts together to brainstorm on cyber security best practices.
FDA's Sept. 20 update to its recalls database includes listings for Doctor Manzanilla Allergy & Decongestant Relief and Cough & Cold oral solutions made by PharmaTech. Also recalled is a mis-labeled Medline Industries ointment.
The Turkish government plans to fix the country’s tamoxifen drug shortage problem by allowing by a local company to manufacture the product.
The spate of recent warning letters going to foreign pharmaceutical manufacturers continues as two Asian firms get into trouble for GMP violations: Firson Co. in South Korea and Wuxi Medical Instrument Factory in China.
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.